On March 4, 2025, Cecil Haney, a Director at Tenet Healthcare Corp (THC, Financial), sold 2,500 shares of the company, as reported in a SEC Filing. Following this transaction, the insider now owns 12,035 shares of the company. Tenet Healthcare Corp (THC) is a diversified healthcare services company. It operates through a network of hospitals, outpatient centers, and other healthcare facilities, providing a wide range of medical services to communities across the United States. Over the past year, Cecil Haney has sold a total of 2,500 shares and has not purchased any shares. The insider transaction history for Tenet Healthcare Corp indicates that there have been no insider buys in total over the past year, while there have been 15 insider sells during the same period. On the day of the recent sale, shares of Tenet Healthcare Corp were trading at $124.26 each, giving the stock a market cap of $11.987 billion. The company's price-earnings ratio stands at 3.91, which is lower than the industry median of 21.835 and also lower than the company's historical median price-earnings ratio. With a trading price of $124.26 and a GF Value of $87.13, Tenet Healthcare Corp has a price-to-GF-Value ratio of 1.43. This suggests that the stock is significantly overvalued based on its GF Value. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow that the stock has traded at. It also includes a GuruFocus adjustment factor based on the company's past returns and growth, as well as future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
